Tuesday, March 22, 2005

Health committee to study ways to add transparency to drug regulatory system

From the Canadian Press:
Health Minister Ujjal Dosanjh has formally asked the Commons health committee to study ways to add transparency to and improve public confidence in the drug regulatory process.

Dosanjh wants the committee to make recommendations on how information learned from post-market surveillance of drugs could be better shared with the public, as well as how the public could become involved in the regulatory process before drugs are approved for sale. ...more

No comments: